What is Jointly?
Jointly operates as a specialized cannabis wellness enterprise, distinguished by its proprietary data platform designed to optimize individual consumption outcomes. The company addresses a critical market gap by providing the industry's first experience-based wellness application, which allows users to track and refine their cannabis usage. By aggregating authentic, unbiased user data, Jointly generates trusted product ratings that establish a new benchmark for performance, taste, and aroma. This data-driven methodology transforms subjective consumption into actionable insights, effectively bridging the gap between product availability and consumer efficacy in the wellness space.
How much funding has Jointly raised?
Jointly has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2022): $5M, investors not publicly disclosed
Key Investors in Jointly
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Jointly?
With this major strategic investment, Jointly is poised to accelerate its market penetration and enhance its data analytics capabilities. The company is expected to focus on scaling its user base and deepening its integration with legal cannabis retailers to further solidify its position as the industry standard for experience-based product evaluation. As the regulatory landscape for cannabis continues to mature, Jointly's commitment to purposeful consumption and data transparency will likely serve as a catalyst for long-term growth and strategic partnerships within the broader health and wellness ecosystem.
See full Jointly company page
